Annals of Family Medicine

NOVEMBER 20, 2024

This can potentially compromise their ability to provide optimal patient care. ’s (2006) framework. long-term nursing homes, clinics), highlighting their perceived needs. Family physicians' pivotal role in prevention and crisis management exposes them to mental stressors due to the highly demanding circumstances.

Family Physician 130

Family Physician Mental Health Family Families 130

FDA Law Blog

MARCH 7, 2024

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.

Clinic 105

Clinic Provider IT Utilities 105

Today's Hospitalist

APRIL 24, 2025

Those interventions included standardizing both bed assignments and nursing handoffs while having ED providers—not an inpatient team—enter skeletal orders when deciding to admit a patient. That checklist includes patient demographics and the individual patient’s clinical needs. Based in Bucks County, Pa.,

Hospital 52

Hospital Patient-Centered Patients Education 52

FDA Law Blog

FEBRUARY 4, 2024

Mullen — On January 18, 2024, the director of FDA’s Center for Devices and Radiological Health and the chief medical officer and acting director of CMS’ Center for Clinical Standards and Quality issued a joint press release supporting FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs). Javitt & Allyson B.

Clinic 59

Clinic Management Medical IT 59

FDA Law Blog

NOVEMBER 1, 2023

Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers. FDA’s position is, however, only one side of the story.

Manufacturing 81

Manufacturing Hospital Healthcare Medical 81

FDA Law Blog

DECEMBER 12, 2022

In an appendix, FDA provides a model “decision check list” for patients. This form lists important risks, including those known or reported to be associated with the use of the LASIK laser devices based on information from clinical trials, scientific literature, and reports from patients who have undergone LASIK.

Manufacturing 52

Manufacturing Provider Patients IT 52

Annals of Family Medicine

NOVEMBER 20, 2024

A US-based study conducted by the Kaiser Family Foundation found 69% of patients reported avoiding discussions about death, but 92% reported feeling somewhat comfortable talking to a heath care provider about EOL wishes. Setting or Dataset: Outpatient palliative care cancer clinic at a tertiary health care center in the U.S.

Patients 130

Patients Patient-Centered Provider Education 130